In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AWP Litigation: Three More Companies Ink Deals With DoJ; Roxane Sets A Record

Executive Summary

The heavy docket of average wholesale price cases got a bit lighter as three pharma companies agreed to pay $421 million to settle claims they inflated the AWP of numerous drugs, thus increasing reimbursement levels.
Advertisement

Related Content

AWP Drumbeat Continues With McKesson’s $151 Mil. Medicaid Fraud Settlement With States
McKesson Closer To Resolving Multi-Year AWP Legal Saga With $190M Federal Settlement
FDA Opened 16 Health Care Fraud Investigations In FY 2011; DoJ Net Tops $4 Billion
Abbott Avoids Compliance Requirements In Kos Off-Label Marketing Settlement
Abbott Avoids Compliance Requirements In Kos Off-Label Marketing Settlement
Abbott Avoids Compliance Requirements In Kos Off-Label Marketing Settlement
AWP Litigation Takes New Twist As Abbott Seeks Sanctions Against DoJ
AWP Litigation Increases As Justice Dept. Sues Roxane For Price Inflation
AWP Litigation Increases As Justice Dept. Sues Roxane For Price Inflation

Topics

Advertisement
UsernamePublicRestriction

Register

PS052922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel